Highlights Hikma Pharmaceuticals PLC

Equities

Market Closed - London S.E. Other stock markets 09:05:22 08/05/2024 pm IST			5-day change	1st Jan Change
1,973 ^GBX	+0.87%		+2.55%	+10.29%

03/05	Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy	MT
03/05	Jefferies cuts AJ Bell; Deutsche likes ConvaTec	AN

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets	26/04
Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024	25/04	CI
Hikma Pharmaceuticals backs outlook after making strong start to 2024	25/04	AN
Hikma Pharmaceuticals Affirms FY24 Guidance	25/04	MT
Hikma Pharmaceuticals PLC Proposes Final Dividend for the Full Year 2023	25/04	CI
Hikma Pharmaceuticals plc Reiterates Earnings Guidance for the Year 2024	25/04	CI
Final dividend	21/03	FA
FTSE 100 Closes Up 0.12% Ahead of U.K. Jobs Data	11/03	DJ
AFT Pharmaceuticals to Expand Global Footprint with Signing of Supply, Production Deals	04/03	MT
AFT Pharmaceuticals Limited Extends License for Maxigesic/Combogesic IV with Hikma Pharmaceuticals	04/03	CI
Hyloris Partner Hikma Launches Pain Medication in US, Obtains Approval in Canada	28/02	MT
Merck's Bridion faces generic threat from drugmaker Hikma	27/02	RE
HIKMA PHARMACEUTICALS : Strong Generics-led finish to 2023	22/02
Hikma boosts dividend after year of "significant progress"	22/02	AN
Drugmaker Hikma expects profit to be slightly lower in 2024	22/02	RE
Hikma Pharmaceuticals Reports Improved FY23 Profit, Revenue	22/02	MT
Earnings Flash (HIK.L) HIKMA PHARMACEUTICALS Posts FY23 EPS $0.85	22/02	MT
Hikma Pharmaceuticals PLC Provides Group Earnings Guidance for the Year 2024	22/02	CI
Hikma Pharmaceuticals PLC Reports Earnings Results for the Full Year Ended December 31, 2023	22/02	CI
Stocks to rise as Nvidia drives AI optimism	22/02	AN

No results for this search

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets

April 26, 2024 at 04:20 pm IST